Logo-bma
Biomed adv. 2026;3(3): 89-91. doi: 10.34172/bma.74

Opinion

Preserving Lean Mass During GLP-1RA-Induced Weight Loss: The Potential Role of Ketogenic Metabolic Therapy in Improving Weight-Loss Quality

Marco Medeot * ORCID

Cited by CrossRef:



Acceptance Rate: 35%
Submission to First Decision: 20 Days
Received to Acceptance: 60 Days
Acceptance to Publication: 40 Days
*Average article statistics from the last 12 months of data.

In collaboration with